You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,371 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
B
MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma
Not yet recruiting
  • Follicular Lymphoma and Marginal Zone Lymphoma
  • Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide
  • lenalinomide
  • (no location specified)
2021-04-05
Apr 5, 2021
A
Maintenance Lenalidomide in Lymphoma
Active, not recruiting
Has Results
  • Lymphoma
  • Lenalidomide
  • Philadelphia, Pennsylvania
    Jakub Svoboda
2021-10-04
Oct 4, 2021
J
Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors - 2018
Terminated
Has Results
  • Central Nervous System Tumors
  • 25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)
  • +4 more
  • Saint Petersburg, Florida
    Johns Hopkins All Childen's Hospital
2021-03-08
Mar 8, 2021
F
Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
Active, not recruiting
  • Multiple Myeloma
  • Melphalan, Prednisone, Lenalidomide
  • +2 more
  • Torino, TO, Italy
    Division Of Hematology, A.O.U. Città della Salute e della Scienz
2020-11-05
Nov 5, 2020
S
Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM
Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
2021-08-20
Aug 20, 2021
U
Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Active, not recruiting
  • Multiple Myeloma
  • Lenalidomide
  • +3 more
  • Chicago, Illinois
  • +2 more
2021-06-29
Jun 29, 2021
P
Lenalidomide and Dexamethasone for Rosai-Dorfman Disease
Recruiting
  • Rosai-Dorfman Disease
  • lenalidomide and dexamethasone
  • Beijing, China
    Peking Union Medical College Hospital
2021-06-11
Jun 11, 2021
N
Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas
Not yet recruiting
  • Peripheral T-cell Lymphomas (PTCL)
  • Lenalidomide and Gemcitabine (Dose level 11)
  • +3 more
  • Kaohsiung, Taiwan
  • +3 more
2021-11-01
Nov 1, 2021
W
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
Active, not recruiting
Has Results
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
2021-05-13
May 13, 2021
M
Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.
Active, not recruiting
  • MULTIPLE MYELOMA (MM)
  • Rionero in Vulture, Italy
    IRCCS--CROB --CROB di Rionero in di Rionero in Vulture
2021-04-28
Apr 28, 2021
H
Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma
Recruiting
  • Central Nervous System Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib
  • +2 more
  • Zhengzhou, Henan, China
    Henan cancer hospital
2021-06-16
Jun 16, 2021
M
Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma
Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Lenalidomide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2021-07-13
Jul 13, 2021
M
Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185) - 2020
Terminated
Has Results
  • Multiple Myeloma
  • Pembrolizumab
  • +2 more
  • (no location specified)
2021-06-29
Jun 29, 2021
G
Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma
Withdrawn
  • Multiple Myeloma
  • Daratumumab Only Product in Parenteral Dose Form
  • Huixquilucan, Estado De México, Mexico
    Grupo Cooperativo de Hemopatías Malignas
2021-07-05
Jul 5, 2021
H
Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide
Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Fludarabine, Cyclophosphamide, Rituximab, Lenalidomide
  • Hackensack, New Jersey
    John Theurer Cancer Center at HackensackUMC
2021-08-25
Aug 25, 2021
N
Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas - 2019
Completed
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Lenalidomide
  • XRT, 54-59.4 Gy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-10-23
Oct 23, 2021
H
Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma - 2020
Completed
Has Results
  • Multiple Myeloma
  • Lenalidomide
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-10-08
Oct 8, 2021
U
Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma
Active, not recruiting
  • Lymphoma
  • Rituximab
  • Lenalidomide
  • Sacramento, California
    University of California Davis Cancer Center
2021-02-04
Feb 4, 2021
B
A Study of Zanubrutinib Versus Lenalidomide in Participants With Relapsed/Refractory Marginal Zone Lymphoma
Not yet recruiting
  • Relapsed/Refractory Marginal Zone Lymphoma
  • (no location specified)
2021-10-21
Oct 21, 2021
B
PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
Recruiting
  • EBV Infection
  • PD1 antibody
  • lenalidomide
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
2021-06-27
Jun 27, 2021
W
BiRd vs. Rd as Initial Therapy in Multiple Myeloma
Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
2021-09-02
Sep 2, 2021
H
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-08-15
Aug 15, 2021
U
Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome
Active, not recruiting
  • Richter's Syndrome
  • CLL
  • La Jolla, California
    University of California, San Diego
2021-04-08
Apr 8, 2021
T
A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone - 2021
Completed
  • Relapsed and/or Refractory Multiple Myeloma
  • Tokyo, Japan
    Takeda Selected Site
2021-06-03
Jun 3, 2021